INVO Bioscience (INVO) Reports Q1 Loss of $0.20

INVO Bioscience (NASDAQ: INVO) reported Q1 EPS of ($0.20). Revenue for the quarter came in at $340 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on INVO Bioscience (INVO) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Mercury Systems (MRCY) Misses Q4 EPS by 2c